These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 37543771)

  • 21. KIF4A as a novel prognostic biomarker in cholangiocarcinoma.
    Zhang DY; Ma SS; Sun WL; Lv XCH; Lu Z
    Medicine (Baltimore); 2021 May; 100(21):e26130. PubMed ID: 34032761
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ARHGAP21 Is Involved in the Carcinogenic Mechanism of Cholangiocarcinoma: A Study Based on Bioinformatic Analyses and Experimental Validation.
    Wang Z; Wu S; Wang G; Yang Z; Zhang Y; Zhu C; Qin X
    Medicina (Kaunas); 2023 Jan; 59(1):. PubMed ID: 36676763
    [No Abstract]   [Full Text] [Related]  

  • 23. Screening of potential biomarkers for cholangiocarcinoma by integrated analysis of microarray data sets.
    Huang QX; Cui JY; Ma H; Jia XM; Huang FL; Jiang LX
    Cancer Gene Ther; 2016; 23(2-3):48-53. PubMed ID: 26679756
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular profiling reveals potential targets in cholangiocarcinoma.
    Liu D; Shi Y; Chen H; Nisar MA; Jabara N; Langwinski N; Mattson S; Nagaoka K; Bai X; Lu S; Huang CK
    World J Gastroenterol; 2023 Jul; 29(25):4053-4071. PubMed ID: 37476584
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tertiary lymphoid structures predict the prognosis and immunotherapy response of cholangiocarcinoma.
    Shang T; Jiang T; Lu T; Wang H; Cui X; Pan Y; Xu M; Pei M; Ding Z; Feng X; Lin Y; Li X; Tan Y; Feng F; Dong H; Wang H; Dong L
    Front Immunol; 2023; 14():1166497. PubMed ID: 37234171
    [TBL] [Abstract][Full Text] [Related]  

  • 26. lnc-PKD2-2-3, identified by long non-coding RNA expression profiling, is associated with pejorative tumor features and poor prognosis, enhances cancer stemness and may serve as cancer stem-cell marker in cholangiocarcinoma.
    Qiu G; Ma D; Li F; Sun D; Zeng Z
    Int J Oncol; 2019 Jul; 55(1):45-58. PubMed ID: 31059014
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of a novel bile marker clusterin and a public online prediction platform based on deep learning for cholangiocarcinoma.
    Gao L; Lin Y; Yue P; Li S; Zhang Y; Mi N; Bai M; Fu W; Xia Z; Jiang N; Cao J; Yang M; Ma Y; Zhang F; Zhang C; Leung JW; He S; Yuan J; Meng W; Li X
    BMC Med; 2023 Aug; 21(1):294. PubMed ID: 37553571
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Unveiling the immunogenomic landscape of cholangiocarcinoma: Identifying new prognostic markers and therapeutic targets based on CCL5 expression.
    Wang J; Xiang D; Dai Z; Zhu J; Du Y; Fu G; Chu X
    J Gene Med; 2024 Jan; 26(1):e3630. PubMed ID: 37985959
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Significance of S100P as a biomarker in diagnosis, prognosis and therapy of opisthorchiasis-associated cholangiocarcinoma.
    Wu Z; Boonmars T; Nagano I; Boonjaraspinyo S; Srinontong P; Ratasuwan P; Narong K; Nielsen PS; Maekawa Y
    Int J Cancer; 2016 Jan; 138(2):396-408. PubMed ID: 26312563
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel three‑miRNA signature predicts survival in cholangiocarcinoma based on RNA‑Seq data.
    Cao J; Sun L; Li J; Zhou C; Cheng L; Chen K; Yan B; Qian W; Ma Q; Duan W
    Oncol Rep; 2018 Sep; 40(3):1422-1434. PubMed ID: 29956786
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum Angiopoietin-Like Protein 4: A Potential Prognostic Biomarker for Prediction of Vascular Invasion and Lymph Node Metastasis in Cholangiocarcinoma Patients.
    Aung TM; Ciin MN; Silsirivanit A; Jusakul A; Lert-Itthiporn W; Proungvitaya T; Roytrakul S; Proungvitaya S
    Front Public Health; 2022; 10():836985. PubMed ID: 35392474
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical correlation of cadherin-17 marker with advanced tumor stages and poor prognosis of cholangiocarcinoma.
    Zheng BH; Shen S; Wong KF; Gong ZJ; Sun WT; Ni XJ; Wang JW; Hu MY; Liu H; Ni XL; Liu HB; Luk JM; Suo T
    J Surg Oncol; 2021 Apr; 123(5):1253-1262. PubMed ID: 33524213
    [TBL] [Abstract][Full Text] [Related]  

  • 33. miR-378 serves as a prognostic biomarker in cholangiocarcinoma and promotes tumor proliferation, migration, and invasion.
    Zhou Z; Ma J
    Cancer Biomark; 2019; 24(2):173-181. PubMed ID: 30594918
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multi-serum glycobiomarkers improves the diagnosis and prognostic prediction of cholangiocarcinoma.
    Silsirivanit A; Matsuda A; Kuno A; Tsuruno C; Uenoyama Y; Seubwai W; Angata K; Teeravirote K; Wongkham C; Araki N; Takahama Y; Wongkham S; Narimatsu H
    Clin Chim Acta; 2020 Nov; 510():142-149. PubMed ID: 32659223
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Revision of potential prognostic markers of cholangiocarcinoma for clinical practice.
    Saengboonmee C; Obchoei S; Sawanyawisuth K; Wongkham S
    Expert Rev Anticancer Ther; 2023 May; 23(5):517-530. PubMed ID: 37052887
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MCM10 as a novel prognostic biomarker and its relevance to immune infiltration in gliomas.
    Tian QS; Zhang Q; Huang W
    Technol Health Care; 2023; 31(4):1301-1317. PubMed ID: 36872806
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circulating microRNA-21 as a prognostic, biological marker in cholangiocarcinoma.
    Liu CH; Huang Q; Jin ZY; Xie F; Zhu CL; Liu Z; Wang C
    J Cancer Res Ther; 2018 Jan; 14(1):220-225. PubMed ID: 29516989
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of Smad7 in cholangiocarcinoma: prognostic significance and implications for tumor metastasis.
    Huang Q; Liu L; Liu CH; Shao F; Xie F; Zhang CH; Hu SY
    Asian Pac J Cancer Prev; 2012; 13(10):5161-5. PubMed ID: 23244128
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Cholangiocarcinoma Prediction Model Based on Random Forest and Artificial Neural Network Algorithm.
    Liao J; Meng C; Liu B; Zheng M; Qin J
    J Coll Physicians Surg Pak; 2023 May; 33(5):578-586. PubMed ID: 37190696
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Micro-RNA-130a-3p Regulates Gemcitabine Resistance via PPARG in Cholangiocarcinoma.
    Asukai K; Kawamoto K; Eguchi H; Konno M; Asai A; Iwagami Y; Yamada D; Asaoka T; Noda T; Wada H; Gotoh K; Nishida N; Satoh T; Doki Y; Mori M; Ishii H
    Ann Surg Oncol; 2017 Aug; 24(8):2344-2352. PubMed ID: 28560603
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.